Upper Gastrointestinal Tract Phenotype of Crohn's Disease Is Associated with Early Surgery and Further Hospitalization

被引:64
作者
Chow, Dorothy K. L. [1 ]
Sung, Joseph J. Y. [1 ]
Wu, Justin C. Y. [1 ]
Tsoi, Kelvin K. F. [1 ]
Leong, Rupert W. L. [2 ]
Chan, Francis K. L. [1 ]
机构
[1] Chinese Univ Hong Kong, Inst Digest Dis, Dept Med & Therapeut, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China
[2] Univ New S Wales, Fac Med, Concord & Bankstown Lidcombe Hosp, Sydney, NSW, Australia
关键词
L4; phenotype; Crohn's disease; hospitalization; INFLAMMATORY-BOWEL-DISEASE; CHINESE POPULATION; PANETH CELLS; EPIDEMIOLOGY; INFLIXIMAB; BEHAVIOR; AGE; CLASSIFICATION; METAANALYSIS; DIAGNOSIS;
D O I
10.1002/ibd.20804
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: According to the Montreal Classification, upper gastrointestinal tract phenotype L4 is uncommon in Caucasian patients with Crohn's disease (CD) but carries excess risk of recurrence. We Studied the clinical Course of CID in Chinese patients presenting with the L4 phenotype and factors predicting its Occurrence upon longitudinal follow-up. Methods: This prospective cohort Study included 132 Chinese CD patients (median age at diagnosis, 30.0),cars, range: 14.0-77.0 years) who were followed for 770 person-years. Demographic data including disease behavior and location, details Of Surgery, and hospitalization were collected. The Kaplan-Meier method was used to estimate the probabilities Of further hospitalization and major surgery followed by Cox proportional hazards regression to determine if clinical variables independently predicted the endpoints. Results: The L4 phenotype was found in 30 (22.7%) patients at presentation. There were significantly more stricturing (46.7% versus 18.6%) and penetrating (30.0% Versus 3.9%) phenotypes in the L4 group than in the non-L4 group (P < 0.0001). The 3-year cumulative probability of further hospitalization was 86.9% (95% confidence interval [CI]: 73.8%-100.0%) in the L4 group as compared with 49.3% (95% Cl: 39.3%-59.3%) in the non-L4 group (log-rank test. P < 0.0001). The L4 phenotype independently predicted further hospitalization (adjusted hazards ratio [HR]: 2.1: 95% Cl: 1.3-3.5). The cumulative probability of major Surgery was significantly higher in the L4 than in the non-L4 group (P < 0.0001). Eighteen (17.6%) patients developed the L4 phenotype on follow-up and the stricturing, phenotype predicted its Occurrence (adjusted HR: 5.5: 95% Cl: 2.2-14.0). Conclusions: Chinese CD patients more often had the L4 phenotype, which predicted the need of subsequent hospitalization.
引用
收藏
页码:551 / 557
页数:7
相关论文
共 29 条
[1]   Does cigarette smoking influence the phenotype of Crohn's disease? (vol 102, pg 577, 2007) [J].
Aldhous, M. C. ;
Drummond, H. E. ;
Anderson, N. ;
Smith, L. A. ;
Arnott, I. D. R. ;
Satsangi, J. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 (04) :915-915
[2]   Predictors of Crohn's disease [J].
Beaugerie, L ;
Seksik, P ;
Nion-Larmurier, I ;
Gendre, JP ;
Cosnes, J .
GASTROENTEROLOGY, 2006, 130 (03) :650-656
[3]   Changes in Crohn's disease phenotype over time in the chinese population: Validation of the Montreal classification system [J].
Chow, Dorothy K. L. ;
Leong, Rupert W. L. ;
Lai, Larry H. ;
Wong, Grace L. H. ;
Leung, Wai-Keung ;
Chan, Francis K. L. ;
Sung, Joseph J. Y. .
INFLAMMATORY BOWEL DISEASES, 2008, 14 (04) :536-541
[4]   The safety profile of infliximab in patients with Crohn's disease: The Mayo Clinic experience in 500 patients [J].
Colombel, JF ;
Loftus, EV ;
Tremaine, WJ ;
Egan, LJ ;
Harmsen, WS ;
Schleck, CD ;
Zinsmeister, AR ;
Sandborn, WJ .
GASTROENTEROLOGY, 2004, 126 (01) :19-31
[5]   Long-term evolution of disease behavior of Crohn's disease [J].
Cosnes, J ;
Cattan, S ;
Blain, A ;
Beaugerie, L ;
Carbonnel, F ;
Parc, R ;
Gendre, JP .
INFLAMMATORY BOWEL DISEASES, 2002, 8 (04) :244-250
[6]   Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease:: an open randomised trial [J].
D'Haens, Geert ;
Baert, Filip ;
van Assche, Gert ;
Caenepeel, Philip ;
Vergauwe, Philippe ;
Tuynman, Hans ;
De Vos, Martine ;
van Deventer, Sander ;
Stitt, Larry ;
Donner, Allan ;
Vermeire, Severine ;
Van De Mierop, Frank J. ;
Coche, Jean-Charles R. ;
van der Woude, Janneke ;
Ochsenkuehn, Thomas ;
van Bodegraven, Ad A. ;
van Hootegem, Philippe P. ;
Lambrecht, Guy L. ;
Mana, Fazia ;
Rutgeerts, Paul ;
Feagan, Brian G. ;
Hommes, Daniel .
LANCET, 2008, 371 (9613) :660-667
[7]   Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: A metaanalysis [J].
Economou, M ;
Trikalinos, TA ;
Loizou, KT ;
Tsianos, EV ;
Ioannidis, JPA .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (12) :2393-2404
[8]   THE EPIDEMIOLOGY OF INFLAMMATORY BOWEL-DISEASE - A LARGE, POPULATION-BASED STUDY IN SWEDEN [J].
EKBOM, A ;
HELMICK, C ;
ZACK, M ;
ADAMI, HO .
GASTROENTEROLOGY, 1991, 100 (02) :350-358
[9]   Paneth cells: Their role in innate immunity and inflammatory disease [J].
Elphick, DA ;
Mahida, YR .
GUT, 2005, 54 (12) :1802-1809
[10]   New serological markers in inflammatory bowel disease are associated with complicated disease behaviour [J].
Ferrante, Marc ;
Henckaerts, Liesbet ;
Joossens, Marie ;
Pierik, Marie ;
Joossens, Sofie ;
Dotan, Nir ;
Norman, Gary L. ;
Altstock, Rom T. ;
Van Steen, Kristel ;
Rutgeerts, Paul ;
Van Assche, Gert ;
Vermeire, Severine .
GUT, 2007, 56 (10) :1394-1403